Decrease in autoantibody titres during long-term treatment of scleroderma with rituximab: a promising surveillance marker of therapy?

作者:Moazedi Fuerst F C*; Kielhauser S M; Hermann J; Meilinger M; Demel U; Stradner M H; Graninger W B
来源:Scandinavian Journal of Rheumatology, 2015, 44(6): 519-520.
DOI:10.3109/03009742.2015.1069888
  • 出版日期2015-11-2